Literature DB >> 29928095

Rare case of atypical femoral fracture with blocked medullary canal associated with bisphosphonate therapy.

A Shetty1, P Shenoy1, A Bari1, R Swaminathan1.   

Abstract

Bisphosphonates are widely used for treatment of osteoporosis and its use is increasing in geriatric population. Atypical femoral fractures are associated with bisphosphonate therapy. We report an unusual case of femoral shaft fracture following bisphosphonate therapy where the femoral canal of the proximal and distal fracture fragments was blocked and its management.

Entities:  

Keywords:  Bisphosphonates; Geriatric; Osteoporosis

Year:  2018        PMID： 29928095      PMCID： PMC6008637          DOI： 10.1016/j.jcot.2018.04.016

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN： 0976-5662


  7 in total

1.  Femoral canal obliteration secondary to prolonged alendronate use: a case report.

Authors:  Chin Tat Lim; Tony Setiobudi; Shamal Das De
Journal:  J Orthop Surg (Hong Kong)       Date:  2012-04       Impact factor: 1.118

2.  Severely suppressed bone turnover: a potential complication of alendronate therapy.

Authors:  Clarita V Odvina; Joseph E Zerwekh; D Sudhaker Rao; Naim Maalouf; Frank A Gottschalk; Charles Y C Pak
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

3.  Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.

Authors:  R N Thompson; J R A Phillips; S H J McCauley; J R M Elliott; C G Moran
Journal:  J Bone Joint Surg Br       Date:  2012-03

4.  Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Peter R Ebeling; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David Dempster; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Kenneth Koval; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Howe Tet Sen; Marjolein C H van der Meulen; Robert S Weinstein; Michael Whyte
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

5.  Clinical correlates of atypical femoral fracture.

Authors:  Joan C Lo; Susie Y Huang; Grace A Lee; Stutee Khandelwal; Stutee Khandewal; Jason Provus; Bruce Ettinger; Joel R Gonzalez; Rita L Hui; Christopher D Grimsrud
Journal:  Bone       Date:  2012-03-04       Impact factor: 4.398

6.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

Review 7.  Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-10-01       Impact factor: 6.741
  7 in total
  1 in total

1.  Skeletal Site-Specific Response of Jawbones and Long Bones to Surgical Interventions in Rats Treated with Zoledronic Acid.

Authors:  Jing Yi Wang; Lei Huo; Ru Qing Yu; Nian Jing Rao; Weijia William Lu; Li Wu Zheng
Journal:  Biomed Res Int       Date:  2019-12-18       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.